Health Condition 1: null- periorbital and eyelid capillary haemangioma
Conditions
Interventions
Intervention1: intralesional propranolol: Group B will receive intralesional propranolol in the form of a single injection with 26 gauge needle. The propranolol used will be provided by the pharmacy o
then 2mg/kg/day in three divided doses on day 3 & 4 and then 3mg/kg/day in three divided doses to be continued
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1 Newly diagnosed cases of periorbital and eyelid capillary haemangiomas 2 Only those patients or whose guardians sign a written informed consent 3 No complications like ulceration/ necrosis 4 No previous intervention 5 No history of any systemic illness including asthma/ heart disease/ diabetes mellitus 6 No history of developmental delay
Exclusion criteria
Exclusion criteria: 1 Patients not willing for treatment or follow up 2 Previously treated patients 3 Presence of systemic illnesses including recurrent breathing problem/ asthma; cardiac problems including AV block, CHF, sinus bradycardia; history of seizures; history of diabetes mellitus - Abnormalities found in blood investigations - Failure to get Cardiology Clearance for the intervention - Additional ocular pathologies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| resolution of lesionTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| No change in size with continuous propranolol for 3 months Timepoint: 3 months;Obvious enlargement of lesion despite continuous treatment for 2 months Timepoint: 2months;Partial regression followed by no response for 3 months Timepoint: 3 months | — |
Countries
India
Contacts
Public Contactaditi mehta
Dr Rajendra Prasad Centre for Ophthalmic Sciences AIIMS
Outcome results
None listed